Video from AACC: Fluxergy's multimodal testing platform

By Leo O'Connor, Editor in Chief
August 2, 2022

Fluxergy president and co-founder Tej Patel sat down with us at AACC 2022 and discussed the company’s multimodal, multiomic platform that enables doctors to perform different kinds of tests, including reverse transcription polymerase chain reaction (RT-PCR) and serology tests, using a single instrument and software program.

Click on the video below for the interview.

Video from AACC: Fluxergy's multimodal testing platform
Fluxergy President Tej Patel.

Video from AACC: First impressions, Day 1
Reflecting on highlights from the and team for Day 1, Kalorama Information's Bruce Carlson compares AACC...
Video from AACC: AACC president on Theranos, VALID Act
Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual...
Fluxergy invests $30M to produce more point-of-care SARS-CoV-2 tests
Diagnostic test company Fluxergy will spend $30 million to expand production of its one-hour point-of-care SARS-CoV-2 detection test.
Fluxergy seeks emergency authorization for 1-hour coronavirus test
Fluxergy is seeking an emergency use authorization from the U.S. Food and Drug Administration to pave the way for medical professionals to use its one-hour,...

Copyright © 2022

Last Updated 8/2/2022 9:41:32 AM